Adverse effects of antipsychotics

Adverse effects of antipsychotics

Up next

EKU Podcast: Irritable bowel syndrome

Irritable Bowel Syndrome (IBS) affects approximately 1 in 20 people in the UK, equating to around 3.2 million individuals, though some estimates suggest up to 1 in 5 adults experience symptoms, with potentially even more not seeking medical help. It's a common digestive disorder, ...  Show more

Challenging Consultations Podcast

Primary care consultations can be challenging for a number of reasons. In this podcast, Dr. Ed Pooley discusses the key skill of relationship building within general practice and how this can be achieved with a variety of consultation techniques. He addresses issues of raised emo ...  Show more

Recommended Episodes

Papers Unplugged: Precision Medicine in AML
EHA Unplugged

In this podcast, hear from Prof Hartmut Döhner, Hematologist-Oncologist and Professor of Medicine in Germany, as he discusses the growing roles of precise treatments based on the characteristics of the leukemic cells in acute myeloid leukemias. Discover the clinical developments ...  Show more

How Psychiatric Medications Work with Dr. Cummings
Psychiatry & Psychotherapy Podcast

In the latest episode of the Psychiatry and Psychotherapy Podcast, Dr. Puder interviews Dr. Cummings, a psychopharmacologist. They discuss the way medicine works in our bodies, and if medicine or therapy is more effective for treating different disorders. They also talk about the ...  Show more

Danielle Elliot: The rise in diagnoses: Why women? Why now?
Women & ADHD

Episode 197 with Danielle Elliot.“I would love to see the conversation move towards less questioning of women when they talk about having ADHD.”Danielle is a health and science journalist, documentarian, and creator and host of Climbing the Walls, a new 6-part podcast series prod ...  Show more

Levomilnacipran Pharmacology
Real Life Pharmacology - Pharmacology Education for Health Care Professionals

In this episode of our pharmacology podcast, we take a deep dive into the pharmacology of levomilnacipran (Fetzima), a unique serotonin-norepinephrine reuptake inhibitor (SNRI) approved for the treatment of major depressive disorder (MDD) in adults. Designed for pharmacy students ...  Show more